SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-197795
Filing Date
2020-07-23
Accepted
2020-07-23 16:18:03
Documents
13
Period of Report
2020-07-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d931562d8k.htm   iXBRL 8-K 29832
  Complete submission text file 0001193125-20-197795.txt   191448

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amgn-20200722.xsd EX-101.SCH 4548
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20200722_def.xml EX-101.DEF 13774
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20200722_lab.xml EX-101.LAB 22822
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20200722_pre.xml EX-101.PRE 14743
6 EXTRACTED XBRL INSTANCE DOCUMENT d931562d8k_htm.xml XML 6401
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 201043831
SIC: 2836 Biological Products, (No Diagnostic Substances)